BrainPhyt is a patented ingredient sourced from the microalgae Phaeodactylum tricornutum and standardized at 2% of fucoxanthin for the support of cognitive health.
Microphyt (Baillargues, France) has announced that its flagship ingredient, BrainPhyt, is now Non-GMO Project Verified. BrainPhyt is a patented ingredient sourced from the microalgae Phaeodactylum tricornutum and standardized at 2% of fucoxanthin for the support of cognitive health. The ingredient is produced using the company’s exclusive Camargue technology, the microalgae used to make BrainPhyt is grown in photobioreactors for sustainable and controlled microalgae culture.
"The Non-GMO Project certification is a significant milestone for BrainPhyt and reflects our commitment to providing natural and safe ingredients for consumers," said Christel Lemaire, Microphyt’s marketing manager, in a press release. "We are confident that this certification will further enhance the trust of our customers and partners in the quality and safety of our products."
According to Microphyt, BrainPhyt was recently validated in a human clinical trial, showing that supplementation with the ingredient supports cognitive health in healthy subjects between the ages of 55 and 75. In the study, 66 participants were given either two 275 mg capsules of BrainPhyt or placebo for 24 weeks. Results showed that supplementation with microalgae ingredient improved memory, executive function, attention, and vigilance. The study has not been published.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.